Beta-adrenergic-receptor blockade in the treatment of anxiety.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000605:Amino Alcohols / Q000627:therapeutic use*; D001007:Anxiety / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D006801:Humans; D010919:Placebos; D013015:Sotalol / Q000627:therapeutic use; D013565:Sympatholytics / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D000605:Amino Alcohols; D010919:Placebos; D013565:Sympatholytics; D013015:Sotalol